A forum for researchers, students and applicants in the field of cyclodextrin technology
In this study, prednisolone-containing ophthalmic formulations were developed with expected optimal permeation without toxic or irritative effects. The toxicity and
A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who
Remdesivir (GS-5734; Gilead Sciences Inc., US) is an investigational nucleoside analog that acts as a competitive inhibitor of viral RNAdependent
RotaChrom Technologies, the developer of the world’s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the launch of
A retrospective study based on data collected from Memorial Sloan-Kettering Cancer Center, New York shows high efficacy and low toxicity
Remdesivir initially was intravenously administrated to treat the Ebola disease however right now it has been administered to treat COVID-19
CycloLab Cyclodextrin R&D Ltd. proudly announces winning of a national grant about the development of cyclodextrin-dervatives for autophagy-associated neurodegenerative diseases.
Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use or development for
The amelioration of postprandial glucose and insulin responses to bread is of great importance since it may have significant beneficial
Despite the interest in CDs as medicinal agents and excipients, the physiochemical properties of CDs and CD derivatives, for example
